Youyi Peng

834 total citations
28 papers, 685 citations indexed

About

Youyi Peng is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Youyi Peng has authored 28 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Organic Chemistry. Recurrent topics in Youyi Peng's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Neuropeptides and Animal Physiology (7 papers). Youyi Peng is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Neuropeptides and Animal Physiology (7 papers). Youyi Peng collaborates with scholars based in United States, Netherlands and Italy. Youyi Peng's co-authors include William J. Welsh, Susan M. Keenan, Sonia Arora, Qiang Zhang, Lawrence P. Wennogle, Joseph P. Hendrick, Richard L. Schroeder, Sangita M. Baxi, Janet T. Peterson and Robert J. Leadley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Youyi Peng

28 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youyi Peng United States 15 298 271 105 105 77 28 685
Serdar Kurtkaya United States 8 434 1.5× 158 0.6× 100 1.0× 83 0.8× 62 0.8× 8 756
Iain Martin United Kingdom 16 235 0.8× 167 0.6× 45 0.4× 80 0.8× 86 1.1× 26 651
Meryem Köse Germany 16 349 1.2× 210 0.8× 42 0.4× 42 0.4× 136 1.8× 25 641
Claudia Vergelli Italy 22 572 1.9× 549 2.0× 172 1.6× 144 1.4× 77 1.0× 64 1.1k
Mirko Rivara Italy 19 437 1.5× 231 0.9× 75 0.7× 55 0.5× 96 1.2× 35 708
Hazel J. Dyke United Kingdom 20 468 1.6× 382 1.4× 82 0.8× 170 1.6× 64 0.8× 30 911
Elena Guaita Italy 9 177 0.6× 274 1.0× 168 1.6× 101 1.0× 50 0.6× 14 589
Letizia Crocetti Italy 19 466 1.6× 306 1.1× 185 1.8× 119 1.1× 70 0.9× 63 866
Lilia Weizel Germany 16 368 1.2× 174 0.6× 229 2.2× 85 0.8× 34 0.4× 34 704
Andy Merritt United Kingdom 15 430 1.4× 224 0.8× 30 0.3× 88 0.8× 95 1.2× 32 816

Countries citing papers authored by Youyi Peng

Since Specialization
Citations

This map shows the geographic impact of Youyi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youyi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youyi Peng more than expected).

Fields of papers citing papers by Youyi Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youyi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youyi Peng. The network helps show where Youyi Peng may publish in the future.

Co-authorship network of co-authors of Youyi Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Youyi Peng. A scholar is included among the top collaborators of Youyi Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youyi Peng. Youyi Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Youyi, Qiang Zhang, & Shan Chen. (2025). Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review. SHILAP Revista de lepidopterología. 4. 2 indexed citations
2.
Peng, Youyi, et al.. (2024). Preclinical Evaluation of Sigma 1 Receptor Antagonists as a Novel Treatment for Painful Diabetic Neuropathy. ACS Pharmacology & Translational Science. 7(8). 2358–2368. 5 indexed citations
4.
Mondal, Arindam, Jacques Y. Roberge, John Gilleran, et al.. (2022). Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells. Cell Communication and Signaling. 20(1). 99–99. 9 indexed citations
5.
Mondal, Arindam, Mehul Vora, Elaine Langenfeld, et al.. (2021). Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells. Cell Communication and Signaling. 19(1). 97–97. 9 indexed citations
6.
Peng, Youyi, Qiang Zhang, & William J. Welsh. (2020). Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. Journal of Medicinal Chemistry. 64(1). 890–904. 12 indexed citations
7.
Peng, Youyi, et al.. (2020). Identification of an irreversible PPARγ antagonist with potent anticancer activity. Pharmacology Research & Perspectives. 8(6). e00693–e00693. 10 indexed citations
8.
Goethem, Nick P. van, Dean Paes, Daniela Puzzo, et al.. (2019). Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition. Cellular Signalling. 62. 109338–109338. 18 indexed citations
9.
Mondal, Arindam, Mehul Vora, Elaine Langenfeld, et al.. (2019). Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. Cell Communication and Signaling. 17(1). 150–150. 6 indexed citations
10.
Kimani, Stanley, Sushil Kumar, Nitu Bansal, et al.. (2017). Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity. Scientific Reports. 7(1). 43908–43908. 46 indexed citations
11.
Wennogle, Lawrence P., et al.. (2017). Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction. Advances in neurobiology. 17. 349–384. 22 indexed citations
12.
Zhu, Hongwen, Jennifer OʼBrien, James P. O’Callaghan, et al.. (2010). Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain. Brain Research. 1342. 11–23. 18 indexed citations
13.
Peng, Youyi, Qiang Zhang, Gretchen L. Snyder, et al.. (2010). Discovery of novel α7 nicotinic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4825–4830. 19 indexed citations
14.
Peng, Youyi, Qiang Zhang, Sonia Arora, et al.. (2009). Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways. Bioorganic & Medicinal Chemistry. 17(17). 6442–6450. 14 indexed citations
15.
Zhang, Qiang, et al.. (2007). Highly Potent Triazole-Based Tubulin Polymerization Inhibitors. Journal of Medicinal Chemistry. 50(4). 749–754. 142 indexed citations
16.
Welsh, William J., Qiang Zhang, & Youyi Peng. (2007). Efficient Method for the Synthesis of Dibenzo[b,f]thiepin-10-ones under Mild Conditions. Heterocycles. 71(2). 389–389. 2 indexed citations
17.
Zhang, Qiang, Youyi Peng, & William J. Welsh. (2006). Efficient New Approach for the Synthesis of N,N-Dialkylamino-1,2,4-triazoles. Heterocycles. 68(12). 2635–2635. 9 indexed citations
18.
Baxi, Sangita M., et al.. (2005). Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. Journal of Thrombosis and Haemostasis. 3(4). 733–741. 85 indexed citations
19.
Peng, Youyi, Susan M. Keenan, & William J. Welsh. (2005). Structural model of the Plasmodium CDK, Pfmrk, a novel target for malaria therapeutics. Journal of Molecular Graphics and Modelling. 24(1). 72–80. 16 indexed citations
20.
Peng, Youyi, Susan M. Keenan, Qiang Zhang, & William J. Welsh. (2005). 3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs. Journal of Molecular Graphics and Modelling. 24(1). 25–33. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026